Bleakley Financial Group’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Buy
16,173
+495
+3% +$7.67K ﹤0.01% 907
2026
Q1
$212K Buy
+15,678
New +$219K ﹤0.01% 748
2025
Q1
– Sell
-13,830
Closed -$172K – 1008
2024
Q4
$172K Buy
13,830
+359
+3% +$4.41K 0.01% 957
2024
Q3
$156K Sell
13,471
-327
-2% -$3.77K ﹤0.01% 945
2024
Q2
$147K Sell
13,798
-126
-0.9% -$1.39K ﹤0.01% 925
2024
Q1
$166K Sell
13,924
-157
-1% -$1.89K ﹤0.01% 906
2023
Q4
$152K Sell
14,081
-476
-3% -$4.56K ﹤0.01% 872
2023
Q3
$144K Sell
14,557
-3,322
-19% -$34.6K 0.01% 816
2023
Q2
$178K Buy
17,879
+4,259
+31% +$40.7K 0.01% 852
2023
Q1
$131K Sell
13,620
-1,404
-9% -$15.6K ﹤0.01% 844
2022
Q4
$167K Buy
+15,024
New +$157K 0.01% 811

Other funds holding VTRS

Bleakley Financial Group's VTRS Position: Q2 2026 in Review

Bleakley Financial Group increased its Viatris (VTRS) stake by 3.2% in Q2 2026, buying an estimated $7.67K and bringing the position to 16,173 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Bleakley Financial Group first reported a position in VTRS in Q4 2022 and has held it in 11 quarters since. 1,033 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Bleakley Financial Group held 16,173 shares of Viatris worth $257K as of Q2 2026.
  • Bleakley Financial Group bought 495 Viatris shares in Q2 2026, an estimated $7.67K.
  • Viatris made up ﹤0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #907 holding.
  • Bleakley Financial Group first reported a position in Viatris in Q4 2022 and has held it in 11 quarters since.
  • 1,033 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.